| Prior CVD (n = 89,920)a | Diabetes only (n = 46,032) | CKD only (n = 13,459) | Diabetes and CKD (n = 13,319) |
---|---|---|---|---|
Age, years, mean (SD) | 77.1 (10.3) | 72.0 (11.3) | 81.1 (9.7) | 77.4 (8.9) |
Cohort, % | ||||
 MarketScan | 8.2 | 18.9 | 3.5 | 4.1 |
 Medicare | 91.8 | 81.1 | 96.5 | 95.9 |
 Males, % | 53.3 | 50.1 | 44.6 | 45.4 |
Race/ethnicity, %b | ||||
 Black, Non-hispanic | 5.5 | 9.0 | 7.7 | 11.7 |
 White, Non-hispanic | 90.4 | 82.8 | 87.7 | 80.1 |
 Other | 4.0 | 8.0 | 4.7 | 8.1 |
Geographic region, % | ||||
 West | 14.4 | 15.5 | 16.2 | 16.3 |
 Midwest | 24.8 | 24.4 | 28.3 | 26.5 |
 Northeast | 20.6 | 18.0 | 18.0 | 17.1 |
 South | 40.2 | 42.1 | 37.5 | 40.0 |
Area-level income, %b | ||||
 < $35,000 | 7.9 | 9.7 | 7.6 | 10.4 |
 $35,000–$49,999 | 33.3 | 34.5 | 32.0 | 35.0 |
 $50,000–$74,999 | 36.8 | 36.6 | 39.6 | 36.5 |
 ≥ $75,000 | 22.0 | 19.2 | 20.8 | 18.2 |
 Smoking, % | 49.3 | 40.2 | 41.2 | 40.1 |
 Hypertension, % | 92.8 | 90.6 | 93.5 | 97.8 |
 History of heart failure, % | 40.1 | 31.9 | 46.7 | 54.4 |
 Depression, % | 30.2 | 25.8 | 28.3 | 30.3 |
 Prior MI hospitalization, % | 18.9 | 0.0 | 0.0 | 0.0 |
 Prior CABG/PCI outside of an MI event, % | 5.2 | 0.0 | 0.0 | 0.0 |
 CABG/PCI during the MI event related to the index date, % | 52.0 | 66.5 | 45.7 | 51.3 |
 Cardiologist care, % | 57.7 | 29.6 | 24.5 | 23.5 |
 Endocrinologist care, % | 2.3 | 8.6 | 2.4 | 11.0 |
 Use of insulin, % | 0.0 | 25.0 | 0.0 | 40.0 |
Statin use and intensity, % | ||||
 No statin | 39.6 | 51.3 | 63.1 | 41.0 |
 Low | 5.7 | 6.4 | 5.8 | 7.5 |
 Moderate | 34.9 | 32.4 | 25.5 | 38.4 |
 High | 19.8 | 9.9 | 5.6 | 13.1 |
 Ezetimibe use, % | 4.2 | 2.3 | 1.6 | 2.9 |
 Antihypertensive medication use, % | 93.0 | 91.4 | 92.5 | 95.7 |